Jennifer L Good - Net Worth and Insider Trading

Jennifer L Good Net Worth

The estimated net worth of Jennifer L Good is at least $573,247 dollars as of 2024-04-27. Jennifer L Good is the See Remarks, 10% Owner of Trevi Therapeutics Inc and owns about 206,204 shares of Trevi Therapeutics Inc (TRVI) stock worth over $573,247. Details can be seen in Jennifer L Good's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer L Good has not made any transactions after 2019-05-09 and currently still holds the listed stock(s).

Transaction Summary of Jennifer L Good

To

Jennifer L Good Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer L Good owns 4 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Trevi Therapeutics Inc (TRVI) , and Juniper Pharmaceuticals Inc (JNP) among others .

Click here to see the complete history of Jennifer L Good’s form 4 insider trades.

Insider Ownership Summary of Jennifer L Good

Ticker Comapny Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2019-06-19 director
TRVI Trevi Therapeutics Inc 2019-05-09 director & 10 percent owner & See Remarks
JNP Juniper Pharmaceuticals Inc 2018-08-14 director
XTLB XTL Biopharmaceuticals Ltd 2008-10-10 director

Jennifer L Good Latest Holdings Summary

Jennifer L Good currently owns a total of 1 stock. Jennifer L Good owns 206,204 shares of Trevi Therapeutics Inc (TRVI) as of May 9, 2019, with a value of $573,247.

Latest Holdings of Jennifer L Good

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRVI Trevi Therapeutics Inc 2019-05-09 206,204 2.78 573,247

Holding Weightings of Jennifer L Good


Jennifer L Good Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer L Good has made a total of 1 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 11,250 shares on May 9, 2019, which cost Jennifer L Good around $112,500.

Insider Trading History of Jennifer L Good

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer L Good Trading Performance

GuruFocus tracks the stock performance after each of Jennifer L Good's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer L Good is -40.12%. GuruFocus also compares Jennifer L Good's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer L Good within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer L Good's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer L Good

Average Return

-67.28%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.69 -40.12 -55.31 -67.28 -49.13 -36.21
Relative Return to S&P 500(%) 14.6 -41.79 -63.06 -69.34 -70.59 -47.81

Jennifer L Good Ownership Network

Ownership Network List of Jennifer L Good

No Data

Ownership Network Relation of Jennifer L Good


Jennifer L Good Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Jennifer L Good is the director of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Technical Officer Joseph Shulman , and EVP & Head of North America Jennifer Chien .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Jennifer L Good made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 252,926 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 252,926 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Jennifer L Good Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer L Good. You might contact Jennifer L Good via mailing address: 15 Great Ring Road, Sandy Hook Ct 06482.

Discussions on Jennifer L Good

No discussions yet.